It is interesting that several other studies showed that G-1, the special agonist of GPER-1, promoted the expression of GPER-1 and inhibited the proliferation of ER negative breast cancer cells, ovarian cancer cells, and prostate cancer cells. This evidence concerns the gene GPER1 and ovarian carcinoma.